GCH1 and non-small cell lung carcinoma: The in vivo experimental data showed that GCH1 overexpression reversed GNA inhibitory effects against tumor growth, suggesting that GNA suppressed malignant progression regarding NSCLC through targeting GCH1 and inducing ferroptosis.